Cris Loiren Rodriguez

Array ( [id] => 7784221 [patent_doc_number] => 20120045777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'NOVEL GENES ENCODING PROTEINS HAVING PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC, AND OTHER USES' [patent_app_type] => utility [patent_app_number] => 13/169686 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 213 [patent_figures_cnt] => 213 [patent_no_of_words] => 110204 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045777.pdf [firstpage_image] =>[orig_patent_app_number] => 13169686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792660 [patent_doc_number] => 20130109629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER' [patent_app_type] => utility [patent_app_number] => 13/806997 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 38773 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662258 [patent_doc_number] => 20110311527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/158672 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6724 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311527.pdf [firstpage_image] =>[orig_patent_app_number] => 13158672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586318 [patent_doc_number] => 20110280828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'METHODS FOR TREATMENT OF MICROBIAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/112850 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 43857 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280828.pdf [firstpage_image] =>[orig_patent_app_number] => 13112850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579746 [patent_doc_number] => 20110293629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists' [patent_app_type] => utility [patent_app_number] => 13/107736 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 47275 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293629.pdf [firstpage_image] =>[orig_patent_app_number] => 13107736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8065063 [patent_doc_number] => 20110244491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'PEPTIDES DERIVED FROM HUMAN BPLP PROTEIN, POLYNUCLEOTIDES CODING FOR SAID PEPTIDES AND ANTIBODIES DIRECTED AGAINST SAID PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/102367 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17796 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244491.pdf [firstpage_image] =>[orig_patent_app_number] => 13102367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184157 [patent_doc_number] => 20120114652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'ANTI-PAI-1 ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/099067 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 82021 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114652.pdf [firstpage_image] =>[orig_patent_app_number] => 13099067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792873 [patent_doc_number] => 20130109842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'AMINO ACID SEQUENCES OF NANOBODIES DIRECTED AGAINST P19 SUBUNIT OF THE HETERODIMERIC CYTOKINE IL-23' [patent_app_type] => utility [patent_app_number] => 13/695312 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9483 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014734 [patent_doc_number] => 20110223130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/090483 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8457 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223130.pdf [firstpage_image] =>[orig_patent_app_number] => 13090483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090252 [patent_doc_number] => 09127066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Methods for treating osteoporosis with anti-IL-20 receptor antibodies' [patent_app_type] => utility [patent_app_number] => 13/087502 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8196 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13087502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8791648 [patent_doc_number] => 20130108617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS)' [patent_app_type] => utility [patent_app_number] => 13/639323 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9329 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11331835 [patent_doc_number] => 09523073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Elisa for a naturally-occurring soluble truncated form of IL-23 receptor' [patent_app_type] => utility [patent_app_number] => 13/065867 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 13731 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13065867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043381 [patent_doc_number] => 20120071422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Therapeutic application of isolated naturally-occuring soluble truncated forms of IL-23 receptor' [patent_app_type] => utility [patent_app_number] => 13/065878 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 18864 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071422.pdf [firstpage_image] =>[orig_patent_app_number] => 13065878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669032 [patent_doc_number] => 20110318301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/076148 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 66309 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13076148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110100 [patent_doc_number] => 20110189131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'ACTIVE VARIANTS OF THE IL-18 BINDING PROTEIN AND MEDICAL USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/074538 [patent_app_country] => US [patent_app_date] => 2011-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10393 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189131.pdf [firstpage_image] =>[orig_patent_app_number] => 13074538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7509931 [patent_doc_number] => 20110256126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/039201 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 75136 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256126.pdf [firstpage_image] =>[orig_patent_app_number] => 13039201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8559906 [patent_doc_number] => 08333968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19' [patent_app_type] => utility [patent_app_number] => 13/032501 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50445 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174249 [patent_doc_number] => 20110177065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'METHODS OF TREATING/PREVENTING INFLAMMATION USING COMBINATION OF IL-1 ANTAGONIST AND IL-18 BINDING PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/027449 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11397 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177065.pdf [firstpage_image] =>[orig_patent_app_number] => 13027449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7997089 [patent_doc_number] => 08080392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'IL-D80 polynucleotides' [patent_app_type] => utility [patent_app_number] => 13/025002 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21586 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080392.pdf [firstpage_image] =>[orig_patent_app_number] => 13025002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509156 [patent_doc_number] => 20120308564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'TREATMENT OF A METABOLIC DISORDER' [patent_app_type] => utility [patent_app_number] => 13/577931 [patent_app_country] => US [patent_app_date] => 2011-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11135 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577931 [rel_patent_id] =>[rel_patent_doc_number] =>)